Type 2 & other diabetes

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial

Cardiovasc DiabetolPublished Post hoc analysis of the REWIND randomised trial

Authors' conclusion

In this post hoc analysis of the REWIND placebo group, WHR, WC and/or WC adjusted for HC were risk factors for MACE-3, CVD-related mortality, and all-cause mortality; while BMI was only a risk factor for HF requiring hospitalization. These findings indicate the need for anthropometric measures that consider body fat distribution when assessing CV risk.

Study context

Population
Placebo group of REWIND: T2D, age ≥ 50 years, previous cardiovascular (CV) event or CV risk factors, BMI ≥ 23 kg/m²placebo group
Participants
4,952 participants
Comparison
BMI vs waist-to-hip ratio (WHR) vs waist circumference (WC) as baseline risk factors for CV outcomes
Primary endpoint
MACE-3
Follow-up
Median 5.4 years
Methodological detailsplacebo group only, Cox proportional hazard models, adjusted for age, sex and LASSO-selected baseline factors, per 1 SD increase
  • Placebo group only
  • Cox proportional hazard models
  • Adjusted for age, sex and LASSO-selected baseline factors
  • Per 1 SD increase

Primary result

As reported in the abstract

Hazard ratio (95% CI)P value
WHRper 1 SD increase
1.11(1.03–1.21)
P = 0.009
WCper 1 SD increase
1.12(1.02–1.22)
P = 0.012
WC adjusted for HCper 1 SD increase; strongest association
1.26(1.09–1.46)
P = 0.002

Per 1 SD increase, as printed

Events in placebo group
663 MACE-3 events

Further findings

OutcomeHR (95% CI)P value
HF requiring hospitalization · median follow-up 5.4 yearsWC · per 1 SD increase1.34 (1.16–1.54)P < 0.001
HF requiring hospitalization · median follow-up 5.4 yearsBMI · per 1 SD increase1.33 (1.17–1.50)P < 0.001
Heart failure (HF) requiring hospitalization — Events
226

Cardiovascular disease (CVD)-related mortality and all-cause mortality · median follow-up 5.4 years

Events
346 CVD-related deaths, 592 all-cause deaths
Results for CVD-related mortality and all-cause mortality were similar to MACE-3

HF requiring hospitalization · median follow-up 5.4 years

WHR and WC adjusted for hip circumference (HC) were not risk factors for HF requiring hospitalization

Interaction with sex

No significant interaction with sex was observed

Original publication

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial. Cardiovasc Diabetol. Published 10 March 2023. doi:10.1186/s12933-023-01757-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.